Legendary investor Warren Buffett has announced he will step down as CEO of Berkshire Hathaway (NYSE: BRK.A) at the end of 2025, marking the end of an iconic era in American business. The 94-year-old billionaire, widely known as the "Oracle of Omaha," made the announcement during Berkshire’s annual shareholder meeting in Omaha, Nebraska.
Buffett has led the conglomerate for over six decades, transforming it into a global investment powerhouse with a diverse portfolio spanning insurance, utilities, railroads, and iconic brands like Apple and Coca-Cola. His disciplined value investing strategy and long-term vision have made him one of the most respected and successful investors in history.
Greg Abel, currently the vice chairman overseeing Berkshire’s non-insurance operations, has been named as Buffett’s successor. Abel has long been considered the heir apparent, with Buffett previously signaling confidence in his leadership capabilities. The appointment ends years of speculation about Berkshire’s succession plan, a topic closely watched by investors.
Under Buffett’s stewardship, Berkshire Hathaway has delivered substantial shareholder value and built a reputation for financial stability and prudent capital allocation. As Abel prepares to take the reins, analysts expect a continuation of Buffett’s long-term, decentralized management style that has guided the company’s success.
Buffett’s retirement signals a major shift in the financial world but reassures stakeholders with a well-planned transition. His departure will be closely followed by markets, but the succession plan reinforces investor confidence in Berkshire Hathaway’s future.
With Greg Abel stepping in, Berkshire is poised to enter a new chapter while remaining anchored in the principles that defined Buffett’s extraordinary legacy. Investors and business leaders alike will be watching closely as this historic leadership transition unfolds.


CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Washington Post Publisher Will Lewis Steps Down After Layoffs
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



